Hyperthrombotic Milieu in COVID-19 Patients
Review
[키워드] alteration
cascade
clinically
Coagulation
coagulation cascade
Coagulopathy
component
coronary syndrome
coronavirus
COVID-19
COVID-19 infection
develop
dominant
Embolism
endothelial cell damage
endothelial damage
endotheliopathy
events
Evidence
experience
extrinsic
fibrinolytic
implication
Kidney failure
marker
mechanism
Microvascular thrombosis
milieu
Mortality
Multisystem organ failure
Myocardial infarction
nuance
Occurrence
Outbreaks
parameter
patients
patients with COVID-19
predictor
probe
Respiratory failure
risk
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV2
shown
stroke
strokes
systemic anticoagulation
systemic manifestations
the patient
therapeutic targets
therapy
Thromboembolic event
Thromboprophylaxis
thrombosis
triggered
venous
venous thromboembolic
VTE
while
widespread
with COVID-19
[DOI] 10.3390/cells9112392 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/cells9112392 PMC 바로가기 [Article Type] Review